J&J sees AI halving the time to generate drug development leads

By Michael Erman

NEW YORK, April 27 (Reuters) - Johnson & Johnson is utilizing artificial quality to slash by fractional the clip it ‌takes to make caller leads for processing drugs, the company's ‌chief accusation serviceman said connected Monday.

Discovering caller products outright and bringing them to marketplace utilizing ​AI is not yet possible, but J&J is utilizing the caller exertion to surface the "potential universe" for promising chemic compounds oregon biologics, CIO Jim Swanson said astatine the Reuters Momentum AI lawsuit successful New York.

"That's inactive ‌a ways away, but ⁠we tin optimize," Swanson said. "We've chopped our pb optimization clip successful half."

The New Jersey-based pharmaceutical and aesculapian instrumentality ⁠company has been moving toward a more-focused attack to AI, honing successful connected halfway processes similar AI-enabled products, cause improvement and proviso concatenation optimization.

"We're trying ​to ​cure cancer," Swanson said. "We request each ​tool that we tin leverage ‌to beryllium capable to bash that."

AI is besides utile successful manufacturing, helium said. The exertion has been helping to find erstwhile to adhd solvent astatine the due clip and temperature.

J&J is besides utilizing AI to streamline mentation of documents for regulators, Swanson said. The accepted process for a ‌clinical proceedings study tin instrumentality 700 to ​900 hours, helium said.

That clip has ​gone from "700 hours to astir ​15 minutes," Swanson said.

Swanson said alternatively than radical being ‌replaced by the technology, helium sees ​using AI arsenic ​an further accomplishment for the company's employees. J&J presently has astir 4,000 accusation exertion employees.

"A bundle technologist isn't getting replaced, present ​their relation is expanding," ‌he said. "Our absorption continues to beryllium connected skills. These are 'and' ​skills, not 'or' skills."

(Reporting by Michael ErmanWriting by Chris Prentice Editing ​by Caroine Humer and Bill Berkrot)